Cargando…

Vascular Endothelial Growth Factor Is Associated with the Morphologic and Functional Parameters in Patients with Hypertrophic Cardiomyopathy

Background. Hypertrophic cardiomyopathy (HCM) is mostly autosomal dominant disease of the myocardium, which is characterized by myocardial hypertrophy. Vascular endothelial growth factor (VEGF) is involved in myocyte function, growth, and survival. The aim of study was to analyze the clinical signif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pudil, Radek, Vasatova, Martina, Fucikova, Alena, Rehulkova, Helena, Rehulka, Pavel, Palicka, Vladimir, Stulik, Jiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735982/ https://www.ncbi.nlm.nih.gov/pubmed/26881205 http://dx.doi.org/10.1155/2015/762950

Ejemplares similares

Using proteomics to identify host cell interaction partners for VgrG and IglJ
por: Proksova, Magdalena, et al.
Publicado: (2020)

Identification of Bacterial Protein Interaction Partners Points to New Intracellular Functions of Francisella tularensis Glyceraldehyde-3-Phosphate Dehydrogenase
por: Kopeckova, Monika, et al.
Publicado: (2020)

The Ubiquitination System within Bacterial Host–Pathogen Interactions
por: Vozandychova, Vera, et al.
Publicado: (2021)

Fractionation of Enriched Phosphopeptides Using pH/Acetonitrile-Gradient-Reversed-Phase Microcolumn Separation in Combination with LC–MS/MS Analysis
por: Ondrej, Martin, et al.
Publicado: (2020)

TCR Triggering Induces the Formation of Lck–RACK1–Actinin-1 Multiprotein Network Affecting Lck Redistribution
por: Ballek, Ondřej, et al.
Publicado: (2016)

HU protein is involved in intracellular growth and full virulence of Francisella tularensis
por: Stojkova, Pavla, et al.
Publicado: (2018)

Targeted Mass Spectrometry Analysis of Clostridium perfringens Toxins
por: Duracova, Miloslava, et al.
Publicado: (2019)

Vascular supply of postresection pancreatic remnant after pancreaticoduodenectomy: A cadaveric study
por: Rousek, Michael, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy: from mutation to functional analysis of defective protein
por: Capek, Pavel, et al.
Publicado: (2011)

Modified activities of macrophages’ deubiquitinating enzymes after Francisella infection
por: Vozandychova, Vera, et al.
Publicado: (2023)

Clinical and morphological features of hypertrophic cardiomyopathy in Korean patients.
por: Park, Y. B., et al.
Publicado: (1989)

Genetic Testing in Patients with Hypertrophic Cardiomyopathy
por: Bonaventura, Jiri, et al.
Publicado: (2021)

Hyaluronan and Collagen in Human Hypertrophic Cardiomyopathy: A Morphological Analysis
por: Hellström, Martin, et al.
Publicado: (2012)

Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis
por: Yang, Ruwen, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Preventative therapeutic approaches for hypertrophic cardiomyopathy
por: Solomon, Tanya, et al.
Publicado: (2020)

A case of Takotsubo cardiomyopathy with apical hypertrophic cardiomyopathy-like morphological changes during recovery
por: Sameshima, Kohei, et al.
Publicado: (2022)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

A visceral mycosis in farmed rainbow trout (Oncorhynchus mykiss) caused by Neopyrenochaeta submersa
por: Řehulka, Jiří, et al.
Publicado: (2023)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Emerging Medical Treatment for Hypertrophic Cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2021)

Amorphous TiO(2) Nanotubes as a Platform for Highly Selective Phosphopeptide Enrichment
por: Kupcik, Rudolf, et al.
Publicado: (2019)

Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia
por: Hons, Jaromir, et al.
Publicado: (2021)

Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
por: Monda, Emanuele, et al.
Publicado: (2022)

Enhancement of musculocutaneous nerve reinnervation after vascular endothelial growth factor (VEGF) gene therapy
por: Haninec, Pavel, et al.
Publicado: (2012)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy masked by pericarditis
por: Nichols, Larry, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_38vipphtipo7ee3va2ahf82vms